Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation
2007

Assessing Recent HIV-1 Infections with a Line Immunoassay

Sample size: 748 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jörg Schüpbach, Martin D Gebhardt, Zuzana Tomasik, Christoph Niederhauser, Sabine Yerly, Philippe Bürgisser, Lukas Matter, Meri Gorgievski, Rolf Dubs, Detlev Schultze, Ingrid Steffen, Corinne Andreutti, Gladys Martinetti, Bruno Güntert, Roger Staub, Synove Daneel, Pietro Vernazza

Primary Institution: University of Zurich, Swiss National Center for Retroviruses

Hypothesis

Can a line immunoassay for HIV confirmation provide information about recent HIV infections?

Conclusion

The INNO-LIA test can extract recency information for HIV infections, improving epidemiologic surveillance without additional costs.

Supporting Evidence

  • 765 HIV-1 infections were newly diagnosed during the study period.
  • 195 infections were classified as recent based on clinical information.
  • BED-EIA identified 65% of recent infections correctly.
  • INNO-LIA algorithms showed 50% and 40% sensitivity with high specificity.
  • Estimates of recent infections were 37% for BED-EIA and 35% for INNO-LIA algorithms.
  • Window-based estimation indicated 41% of the population had recent infections.
  • INNO-LIA provides recency information at no additional cost.

Takeaway

Scientists found that a test used to confirm HIV can also tell if someone got infected recently, which helps track the spread of the virus.

Methodology

The study evaluated the INNO-LIA HIV I/II Score assay against the BED-EIA test in newly diagnosed HIV infections in Switzerland.

Potential Biases

Potential misclassification of recent infections due to varying antibody responses in different HIV subtypes.

Limitations

The study's estimates may be biased due to the unknown composition of unclassified infections.

Participant Demographics

All participants were newly diagnosed HIV-1 infections in Switzerland.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 36%–46%

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pmed.0040343

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication